SET and colorectal carcinoma: Previous data reporting that miR-199b directly targets SET in CRC and that miR-199b downregulation is a frequent event that facilitates SET overexpression in metastatic CRC prompted us to analyze the potential contribution of this alteration to deregulate SET also in early-stage CRC.